SONA Sona Nanotech Inc.

0.1818USD0.2600 CAD · CNQ+1.96%Mkt Cap: 22.32M USDP/E: —

Sona Nanotech Inc. operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor…

Institutional holders1 on file

Key Statistics

Company
Market Cap22.32M USD
Enterprise Value22.12M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-2.27M USD
Revenue/Share—
Last Price0.1818 USD
Fiscal Year EndOct 2025
MR QuarterJul 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA83541C1059
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-17.49
EV/Revenue—
P/S—
P/B-23.64
EPS (TTM)-0.02 USD
EPS (Forward)—
52W Range
0.16783% of range0.5872
52W High0.5872 USD
52W Low0.1678 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE8381.93%
ROA-244.46%
ROIC-1897.76%
ROCE-1277.26%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.37M USD
CapEx (TTM)—
FCF Margin—
FCF Yield0.13%
Net Debt225.75K USD
Net Debt/EBITDA-0.18
Net Debt/FCF7.74
Balance Sheet
Debt/Equity-7.94
Current Ratio0.04
Quick Ratio0.01
Book Value/Sh-0.0077 USD
Cash/Share0.00 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.122.80M
Float104.74M
Insiders17.63%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.01%
Shares Short8.20K
Short (prev mo.)1.06K
Technical
SMA 500.2157 (-15.7%)
SMA 2000.2264 (-19.7%)
Beta1.11
S&P 52W Chg12.00%
Avg Vol (30d)58.37K
Avg Vol (10d)26.22K
Technical Indicators
RSI (14)43.3
MACD-0.0125
MACD Signal-0.0111
MACD Hist.-0.0014
BB Upper0.2111 USD
BB Middle0.1914 USD
BB Lower0.1716 USD
BB Width20.65%
ATR (14)0.0149 USD
Vol Ratio (20d)0.51x

About Sona Nanotech (CNSX: SONA)

›

Sona Nanotech (CNSX: SONA) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.

The shares were at 0.2600 CAD on 19 November 2026, down 54.4% over 52 weeks. Its 52-week range is 0.2400 CAD to 0.8400 CAD: the price is 69.0% below the high and 8.3% above the low.

Its market capitalisation is 31.93M CAD.

Sona Nanotech reports an operating margin of 0.0%.

Its debt exceeds its cash by 322.95K CAD. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health.